Moderna | MRNA - Ativo Circulante





Ativo Circulante Alterar Data
Acadia Pharmaceuticals USD 1.27B 43.88M 2026-09
Agios Pharmaceuticals USD 752.1M 34.43M 2026-09
Alnylam Pharmaceuticals USD 5.11B 492.49M 2026-09
Amgen USD 34.36B 598M 2026-09
Arrowhead Research USD 1.29B 382.19M 2026-09
Biogen USD 7.58B 278.7M 2026-09
BioMarin Pharmaceutical USD 3.92B 50.99M 2026-09
Celltrion KRW 493.66B 12.09B 2026-06
Cspc Pharmaceutical CNY 22.25B 359.48M 2025-12
Deva Holding AS TRY 9.13B 1.61B 2023-09
Dianthus Therapeutics USD 856.04M 41.5M 2026-09
Divis Laboratories Ltd INR 124.39B 13.43B 2026-09
Gilead Sciences USD 16.55B 4.02B 2026-09
GlaxoSmithKline GBP 17.9B 336M 2026-09
Incyte USD 5.52B 505.2M 2026-09
Ionis Pharmaceuticals USD 2.36B 129.77M 2026-09
Kangmei Pharma CNY 6.66B 143.43M 2026-06
Knight Therapeutics CAD 394.84M 5.86M 2025-12
Laboratorios Farma EUR 509.33M 128.63M 2023-12
Malin Corporation EUR 62.6M 26.7M 2024-12
Moderna USD 7.34B 1.53B 2026-09
Organigram Holdings CAD 280.09M 30M 2026-06
Ovoca Bio EUR 2.07M 510K 2025-12
Pharma Mar EUR 295.56M 14.62M 2026-09
Puma Biotechnology USD 143.58M 7M 2025-09
Qiagen NV USD 1.66B 116.37M 2026-06
Regeneron Pharmaceuticals USD 20.8B 2.35B 2026-09
Sangamo BioSciences USD 49.89M 12.3M 2025-06
Sarepta Therapeutics USD 2.27B 49.06M 2026-09
Sartorius EUR 1.65B 8.4M 2026-09
Sino Biopharmaceutical CNY 33.82B 9.13B 2025-06
Tilray USD 729.32M 28.18M 2025-09
Ultragenyx Pharmaceutical USD 544M 62M 2026-09
United Therapeutics USD 2.88B 603.5M 2026-09
Vertex Pharmaceuticals USD 11.69B 857.4M 2026-09
Zealand Pharma A/S 15.02B 652.12M 2026-03
Zz Pientze Pharmaceu CNY 13.48B 2.32B 2026-09